| |
Study group (N = 272)
|
Control group (N = 283)
|
P-value
|
---|
Patient readmission rate (N, %)
|
28 days
|
11, 4.0%
|
29, 10.2%
|
0.005a
|
|
84 days
|
22, 8.1%
|
55, 19.4%
|
<0.001a
|
Readmission LOS
|
28 days
|
2.7 (1.4, 4.1)
|
5.0 (2.6, 7.3)
|
0.456b
|
(Mean, 95% CI)
|
84 days
|
4.5 (2.6, 6.4)
|
6.0 (4.0, 8.0)
|
0.607b
|
Utility
|
Baseline
|
0.723 (0.707, 0.739)
|
0.735 (0.719, 0.752)
|
0.308c
|
(Mean, 95% CI)
|
28 days
|
0.764 (0.748, 0.781)
|
0.727 (0.710, 0.744)
|
<0.001c
|
|
84 days
|
0.778 (0.762, 0.795)
|
0.751 (0.734, 0.768)
|
0.002c
|
|
Within group comparison
|
<0.001d
|
0.011 d
| |
QALY gain from baseline
|
28 days
|
0.0016 (0.0010, 0.0022)
|
−0.0003 (−0.0009, 0.0003)
|
<0.001b
|
(Mean, 95% CI)
|
84 days
|
0.0089 (0.0060, 0.0117)
|
0.0003 (−0.0024, 0.0030)
|
<0.001b
|
-
a Pearson's chi-squared test,
-
b Mann–Whitney U-test,
-
c ANCOVA test (28 days and 84 days adjusted by baseline),
-
d Repeated measures ANOVA.